NL-OMON42584WithdrawnNot Applicable
In Vitro Characterization and Enhancement of HIV-Specific CD8+ T Cells - CD8+ T cells in HIV
Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites396 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Withdrawn
- Enrollment
- 396
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Age >18 years
- •Confirmed HIV-1 infection
- •Treatment or viral loads that fit into one of the study groups
Exclusion Criteria
- •Inability to donate 50 ml of blood
- •Pregnancy or breastfeeding
- •Major comorbidities
Investigators
Similar Trials
Active, not recruiting
Phase 1
Intracellular boosting of HIV protease inhibitors through inhibition of transport - a novel strategy for potentiating HIV therapy - Intracellular Boosting of HIV Protease InhibitorsThis study is to evaluate the intracellular boosting effect of furosemide and dipyridamole of the HIV protease inhibitors in HIV positive patients.EUCTR2008-002627-90-GBRoyal Liverpool and Broadgreen University Hospitals NHS Trust100
Recruiting
Not Applicable
Clinical investigation of HIV infection diagnostic kitHIV infectionJPRN-UMIN000021201Keio University School of Medicine Center for Infectious Disease and Infection Control200
Completed
Phase 2
A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to RaltegravirInfection, Human Immunodeficiency VirusNCT00950859ViiV Healthcare51
Completed
Phase 1
The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ARTHIV-1 InfectionNCT01319383University of North Carolina, Chapel Hill25
Completed
Not Applicable
An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected PatientsHIV InfectionsNCT00000650National Institute of Allergy and Infectious Diseases (NIAID)12